The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021

BACKGROUND: Cardiometabolic disease is a clinical syndrome characterized by multiple metabolic disorders, with atherosclerosis as the core and cardiovascular and cerebrovascular events as the outcome. Drug research and development (R&D) in cardiometabolic diseases has grown rapidly worldwide. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chen, Hao, Jun, Zheng, Yitian, Wang, Chuangshi, Yang, Jie, Wang, Wenyao, Zhang, Kuo, Shao, Chunli, Hui, Wen, Wang, Jiancheng, Li, Wei, Tang, Yi-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067219/
https://www.ncbi.nlm.nih.gov/pubmed/37005689
http://dx.doi.org/10.1186/s13098-023-01043-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067219/
https://www.ncbi.nlm.nih.gov/pubmed/37005689
http://dx.doi.org/10.1186/s13098-023-01043-8

Ejemplares similares